financetom
Business
financetom
/
Business
/
BRIEF-Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Aug 5, 2025 6:59 AM

Aug 5 (Reuters) - Y-mAbs Therapeutics Inc ( YMAB ):

* SERB PHARMACEUTICALS AGREES TO ACQUIRE Y-MABS THERAPEUTICS

* Y-MABS THERAPEUTICS INC ( YMAB ): SERB TO COMMENCE ALL-CASH TENDER

OFFER

TO ACQUIRE ALL OUTSTANDING SHARES OF Y-MABS FOR $8.60 PER SHARE

* Y-MABS THERAPEUTICS INC ( YMAB ) - SERB TO BUY Y-MABS IN $412

MILLION

DEAL

* Y-MABS THERAPEUTICS INC ( YMAB ) - SERB OFFERS $8.60 PER SHARE FOR

Y-MABS, 105% PREMIUM

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved